Dr. Xu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
T-209
New Haven, CT 06510Phone+1 203-688-2259Fax+1 203-688-5599
Summary
- Dr. Mina Xu is a pathologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital. She received her undergrad degree from Harvard University, her medical degree from University of California San Francisco School of Medicine. She completed residency in anatomical and clinical pathology at Yale, and fellowship in hematopathology at Brigham&Women’s Hospital. She has been in practice 11 years, and is the director of hematopathology at Yale.
Education & Training
- Brigham and Women's HospitalFellowship, Hematopathology, 2010 - 2011
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- University of California San Francisco School of MedicineClass of 2006
- Harvard UniversityAB, Biology, Honors, 1996 - 2000
Certifications & Licensure
- CT State Medical License 2011 - 2025
- TN State Medical License 2014 - 2020
- AL State Medical License 2014 - 2019
- FL State Medical License 2015 - 2019
- IN State Medical License 2009 - 2019
- NC State Medical License 2014 - 2019
- NJ State Medical License 2016 - 2019
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- Angioimmunoblastic T-cell lymphoma: Current Diagnostic Insights and Advances.Nana P Matsumoto, Mina L Xu
Human Pathology. 2024-11-19 - Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues.Zhiliang Bai, Dingyao Zhang, Yan Gao, Bo Tao, Daiwei Zhang
Cell. 2024-11-14 - 1 citationsData-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti
The Lancet. Haematology. 2024-11-01
Abstracts/Posters
- Heterogeneous Genetic Alterations and Novel Pathogenic Pathways in Relapsed DLBCL Revealed By Whole Exome SequencingMina L Xu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell TransplantationMina L Xu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- New Barcode Technology Could Help Diagnose Cancer More PreciselySeptember 30th, 2024
- Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid OrgansOctober 20th, 2021
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: